Status report
Get it in writing
The official USPTO status record for TEST, TALK AND TREAT - IN THE SAME VISIT., serial 97744133, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
TEST, TALK AND TREAT - IN THE SAME VISIT.Serial 97744133 · Principal Register
Live · Registered
Owner: Visby Medical, Inc.
Class 005 - Pharmaceuticals
Class 010 -
Filed Jan 06, 2023
Registered Feb 04, 2025
The record shows that the mark “TEST, TALK AND TREAT – IN THE SAME VISIT.” is live and registered on the Principal Register under serial 97744133, owned by Visby Medical, Inc., a Delaware corporation. It protects pharmaceutical and medical diagnostic apparatus goods, specifically specimen collection kits and diagnostic devices for infectious, cancer, and neurological diseases, first used in commerce on March 14, 2023. A similar name would raise the closest concern in the same medical specimen and diagnostic apparatus categories, while use in unrelated fields would be farther from the scope shown. The record does not give control over every use of the wording. The prosecution history shows a smooth path to registration with no opposition or enforcement actions recorded. The latest event is the registration confirmation on February 4, 2025. No enforcement signals appear in the supplied history. If you plan to use a similar name in medical specimen or diagnostic equipment, this record suggests a meaningful risk of conflict.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.